Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Jan. 18, 2018

Expand your knowledge, network with IBD leaders and get inspired to improve patient care.

Principles of Gastroenterology for the NP and PA

Aug. 11, 2017

Hear from the experts as they provide you with critical updates on treating and managing patients with a variety of GI disorders.

Primary Care Providers Can Treat Hep C

July 20, 2017

Primary care physicians and nurse practitioners can achieve cure rates matching those of liver disease specialists

Link Between Antibiotics and IBD Remains Circumstantial

July 20, 2017

Effect stronger in children, and underscores need for antibiotic stewardship in prescribing for pediatric infections

Transform IBD Patient Care, Accelerate IBD Research

July 20, 2017

The inaugural Crohn’s & Colitis Congress™, Jan. 18-20, 2018, in Las Vegas, will be the must-attend meeting for practitioners and research investigators in the field of inflammatory bowel disease (IBD).

Earn CME and MOC at Your Convenience

July 12, 2017

Ordering the 2017 AGA Postgraduate Course online sessions gives you the chance to earn continuing medical education credits at your leisure.

Researchers in North America: Get Funding Now

July 11, 2017

The next deadlines for AGA research grant applications are Aug. 4 and Sept. 8, 2017.

Lung-Gut Crosstalk: Airway Disease and IBD

July 6, 2017

Shared inflammatory pathways and genetics may predispose patients with respiratory conditions to developing IBD.

Crohn's & Colitis Congress Registration Open

July 5, 2017

The Crohn’s & Colitis Congress will take place Jan. 18-20, 2018, in Las Vegas.

New Patient Education Section Launched in CGH

July 3, 2017

One-page write-ups on digestive disorders will be available each month to help you engage with your patients.

Watch IBD Program Highlights from DDW® 2017

June 26, 2017

The Immunology, Microbiology & Inflammatory Bowel Diseases Section highlights its favorite sessions from Chicago.

IBD: Research Showing Yoga as Effective Complementary Tx

June 22, 2017

Yoga intervention could be an effective complementary treatment for inflammatory bowel disease.

White Paper AGA: The Impact of Mental and Psychosocial Factors on the Care of Patients With Inflammatory Bowel Disease

June 22, 2017

This white paper details psychosocial care that is integrated into IBD practices as well as innovative methods that provide remote patient management.

Temporal Trends in Initiation of Therapy With Tumor Necrosis Factor Antagonists for Patients With Inflammatory Bowel Disease: A Population-based Analysis

June 22, 2017

Use of anti-TNF agents increased from 2001 through 2014, with a concomitant significant decrease in cumulative use of corticosteroids before anti-TNF therapy for patients with UC.

Considerations in Use of Biosimilars for Gastrointestinal Disorders

June 21, 2017

Considerations in Use of Biosimilars for Gastrointestinal Disorders

Member Benefit Spotlight: GastroSlides

June 15, 2017

Free access to AGA's GastroSlides is now a member benefit.

Course for NPs and PAs Benefits All Experience Levels

June 14, 2017

Find out how AGA's popular course, Principles of GI for the NP and PA, benefits all those who attend, regardless of experience level or practice setting.

Did You Miss AGA Sessions at DDW® 2017?

June 14, 2017

Check out more than 100 hours of AGA Institute Council sessions with DDW On Demand.

Depression and Anxiety May Have Cause-and-Effect Role in IBD

June 8, 2017

Disordered mood can precede IBD relapse, and patients with active disease can benefit from psychological screening and intervention.

IBD and Vitamin D: Exploring the Link

June 8, 2017

The relationship may be bidirectional though it remains unclear whether vitamin D deficiency is a cause or an effect of IBD.

Advent of Biosimilar Products in US GI Practice

June 8, 2017

Advent of Biosimilar Products in US GI Practice

2017-18 AGA GI Resource Catalog is Now Available

June 6, 2017

Download the catalog to find resources that will address all of your professional needs.

Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression

June 1, 2017

We assessed the risk of PJP in a population-based cohort of patients with IBD treated with corticosteroids, immune-suppressive medications, and biologics.

Advent of Biosimilar Products in US GI Practice

June 1, 2017

Biosimilars have become a hot topic, but are you prepared to talk to your patients about optimum use?